Stem Cell

California Stem Cell Report
Fallout From the Trounson Affair: A Taint on the California Stem Cell Agency

Fallout From the Trounson Affair: A Taint on the California Stem Cell Agency

Directors of the $3 billion California stem cell agency meet tomorrow in the San Francisco Bay Area, but the hottest topic is not on the agenda, and that is the Trounson Affair.


Alan Trounson
SF Business Times photo
The term is shorthand for the host of questions raised by

California Stem Cell Report
Cloaking Informed Consent in Clinical Trials: A California Stem Cell Case

Patients come first. That’s the rhetoric from biotech companies and agencies like the FDA, which has oversight responsibilities for clinical trials.


But when it comes down to specifics, the doors may close and little revealed publicly.


The case in point involves StemCells, Inc., which was charged last week in a lawsuit with endangering patients...

California Stem Cell Report
Coming Up: Live Coverage of Thursday’s California Stem Cell Board Meeting

The California Stem Cell Report will provide live, gavel-to-gavel coverage of this Thursday’s meeting of the 29 members of the governing board of the $3 billion California stem Cell agency, which is expected to lop $15 million from its ambitious Alpha stem cell clinic proposal.


Interested parties in Canada will be able to participate...

California Stem Cell Report
California Stem Cell CEO Randy Mills on Focus and Four-Part Tests

It was a case of CEOs interviewing CEOs.


More specifically, it was Robin Smith, head of Neostem, Inc., “grilling” Randy Mills, the new CEO of the $3 billion California stem cell agency. The venue was the Huffington Post.


It wasn’t exactly hard ball stuff, as one might expect. Nonetheless it was the lengthiest such exchange with Mills, the former...

California Stem Cell Report
Verastem Bid for Nearly $10 Million from California Nixed

A Massachusetts firm called Verastem, Inc., heard some bad news recently about its pitch for $9.9 million from the $3 billion California stem cell agency.


The Cambridge firm sought the cash from the agency to help out with a clinical trial dealing with breast cancer.


However, the agency’s directors were told in...

California Stem Cell Report
Scripps Confirms Marletta’s Plan to Leave as President

The Scripps Research Institute has confirmed the departure of Michael Marletta as its president in a 72-word statement, but details about who will replace him and when are yet to emerge.The move was announced this morning at a meeting at the 2,900-empl...

California Stem Cell Report
Scrips Research President Resigns Following Financial Problems at the Institute

Michael Marletta today resigned as head of The Scripps Research Institute, one of nation’s leading biomedical research organizations, in the wake of an aborted, $600 million merger with the University of Southern California.


Bradley Fikes and Gary Robbins of the San Diego U-T reported that the announcement of his resignation came at a...

California Stem Cell Report
California’s Far-Reaching Alpha Stem Cell Clinic Plan Likely to Take Big Hit

California’s Far-Reaching Alpha Stem Cell Clinic Plan Likely to Take Big Hit

The new president of the California stem cell agency today recommended slashing $15 million from the agency’s ambitious Alpha stem cell clinic plan, declaring that the proposal’s $70 million cost is “not clearly justified.”


If the agency’s board goes along with the recommendation at Thursday’s meeting, it will be the first time the $3...

California Stem Cell Report
Creating Critical Mass at a California Stem Cell Consortium

News about the California stem cell agency is dominated by such matters as $70 million Alpha stem cell rounds and clinical trials but other significant activities occur below that high level surface.


One such event is the creation of a state-of-the-art imaging facility at the Sanford Consortium in the San Diego, a facility that...

California Stem Cell Report
Los Angeles Times: California Stem Cell Agency Rife with Conflicts and Unrealistic Expectations

The Los Angeles Times, California’s largest circulation newspaper, is carrying a piece this weekend about “cronyism,” conflicts of interest and “inflated expectations” at the state’s $3 billion stem cell agency.


The column by Pulitzer Prize-winning writer and author Michael Hiltzik used this month’s Trounson Affair as a starting point to dissect the situation...

Stay connected to Sacramento Connect

Follow Sacramento Connect on Twitter  Find Sacramento Connect on Facebook  Sign up for the Sacramento Connect Newsletter

Advertisement

Categories

  • Hot Topics (2)
  • Shopping (790)
  • Top Stories (3424)

Advertisement